| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 2127* | 2020 |
| Genomic hallmarks of localized, non-indolent prostate cancer M Fraser, VY Sabelnykova, TN Yamaguchi, LE Heisler, J Livingstone, ... Nature 541 (7637), 359-364, 2017 | 649 | 2017 |
| Molecular landmarks of tumor hypoxia across cancer types V Bhandari, C Hoey, LY Liu, E Lalonde, J Ray, J Livingstone, R Lesurf, ... Nature genetics 51 (2), 308-318, 2019 | 607 | 2019 |
| A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing TS Alioto, I Buchhalter, S Derdak, B Hutter, MD Eldridge, E Hovig, ... Nature communications 6 (1), 1-13, 2015 | 342 | 2015 |
| Combining tumor genome simulation with crowdsourcing to benchmark somatic single-nucleotide-variant detection AD Ewing, KE Houlahan, Y Hu, K Ellrott, C Caloian, TN Yamaguchi, ... Nature methods 12 (7), 623-630, 2015 | 341 | 2015 |
| Molecular evolution of early-onset prostate cancer identifies molecular risk markers and clinical trajectories C Gerhauser, F Favero, T Risch, R Simon, L Feuerbach, Y Assenov, ... Cancer cell 34 (6), 996-1011. e8, 2018 | 267 | 2018 |
| The evolutionary landscape of localized prostate cancers drives clinical aggression SMG Espiritu, LY Liu, Y Rubanova, V Bhandari, EM Holgersen, LM Szyca, ... Cell 173 (4), 1003-1013. e15, 2018 | 254 | 2018 |
| Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories RA Taylor, M Fraser, J Livingstone, SMG Espiritu, H Thorne, V Huang, ... Nature communications 8 (1), 13671, 2017 | 252 | 2017 |
| The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact LF van Dessel, J van Riet, M Smits, Y Zhu, P Hamberg, ... Nature communications 10 (1), 5251, 2019 | 191 | 2019 |
| Exploring genetic suppression interactions on a global scale J Van Leeuwen, C Pons, JC Mellor, TN Yamaguchi, H Friesen, ... Science 354 (6312), aag0839, 2016 | 191 | 2016 |
| TMPRSS2–ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer KJ Kron, A Murison, S Zhou, V Huang, TN Yamaguchi, YJ Shiah, M Fraser, ... Nature genetics 49 (9), 1336-1345, 2017 | 189 | 2017 |
| Precision radiotherapy: reduction in radiation for oropharyngeal cancer in the 30 ROC trial N Riaz, E Sherman, X Pei, H Schöder, M Grkovski, R Paudyal, N Katabi, ... JNCI: Journal of the National Cancer Institute 113 (6), 742-751, 2021 | 147 | 2021 |
| Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial F Nassiri, V Patil, LS Yefet, O Singh, J Liu, RMA Dang, TN Yamaguchi, ... Nature medicine 29 (6), 1370-1378, 2023 | 140 | 2023 |
| Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations R Böttcher, CF Kweldam, J Livingstone, E Lalonde, TN Yamaguchi, ... BMC cancer 18, 1-11, 2018 | 135 | 2018 |
| Divergent mutational processes distinguish hypoxic and normoxic tumours V Bhandari, CH Li, RG Bristow, PC Boutros Nature communications 11 (1), 737, 2020 | 122 | 2020 |
| Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer S Zhou, JR Hawley, F Soares, G Grillo, M Teng, SA Madani Tonekaboni, ... Nature communications 11 (1), 441, 2020 | 78 | 2020 |
| Genome-wide germline correlates of the epigenetic landscape of prostate cancer KE Houlahan, YJ Shiah, A Gusev, J Yuan, M Ahmed, A Shetty, ... Nature medicine 25 (10), 1615-1626, 2019 | 65 | 2019 |
| Cistrome partitioning reveals convergence of somatic mutations and risk variants on master transcription regulators in primary prostate tumors P Mazrooei, KJ Kron, Y Zhu, S Zhou, G Grillo, T Mehdi, M Ahmed, ... Cancer Cell 36 (6), 674-689. e6, 2019 | 61 | 2019 |
| Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective R Mathur, Q Wang, PG Schupp, A Nikolic, S Hilz, C Hong, NR Grishanina, ... Cell 187 (2), 446-463. e16, 2024 | 57 | 2024 |
| Combining accurate tumor genome simulation with crowdsourcing to benchmark somatic structural variant detection AY Lee, AD Ewing, K Ellrott, Y Hu, KE Houlahan, JC Bare, SMG Espiritu, ... Genome biology 19, 1-15, 2018 | 52 | 2018 |
